Clinical trial Recruiting at 1 site Interventional Ages 50 and up

Nature-based virtual reality program for depression in Alzheimer's patients

Official title: Nature-based Virtual Reality Intervention for Depression in Alzheimer's Disease: a Pilot Randomized Controlled Trial

Run by Centre for Addiction and Mental Health · NCT06732128 · Data updated 2026-11-12

This study is testing if a nature-based virtual reality program can help reduce depression in people with Alzheimer's disease by providing enjoyable sessions at home.

Quick facts

Study typeInterventional
Ages50 Years and up
SexAll
Enrollment50 (estimated)
SponsorCentre for Addiction and Mental Health
Academic / other
Locations1 site (Toronto, Ontario)
StatusRecruiting
StartedJanuary 6, 2025
Main results expectedJune 11, 2025
Study endsNovember 11, 2025
Registry record updatedDecember 13, 2024
Trial IDNCT06732128 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Ideal candidates are individuals aged 50 and older with a clinical diagnosis of mild to early-moderate Alzheimer's disease and experiencing mild depressive symptoms.

Probably not a fit

Patients with unstable medical or psychiatric conditions, significant visual or hearing impairments, or severe depressive symptoms may not benefit from this intervention.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This intervention involves a 4-week program utilizing nature-based virtual reality (VR) sessions delivered in-home to address behavioral and psychological symptoms of dementia (BPSD), particularly depression, in individuals with Alzheimer's disease. Participants will engage in 15-minute VR sessions twice a week, with the option for caregivers to provide feedback on the intervention. The study aims to assess the feasibility and effectiveness of VR as a non-pharmacological treatment for depression in older adults with dementia, addressing barriers such as accessibility and adherence to traditional therapies.

Why it matters

Potential benefit: If successful, this program could enhance the quality of life for Alzheimer's patients by reducing depressive symptoms and prolonging their ability to live independently.

How similar studies have gone: While previous literature on VR interventions for older adults is limited, the approach is innovative and has not been extensively tested in this specific context.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* Clinical diagnosis of mild to early-moderate stage AD (including mixed dementia with AD) using the Diagnostic and Statistical Manual of Mental Disorders, 5th Ed. Criteria
* Age of 50 years or older
* Medical stability to participate in the trial
* Patient Health Questionnaire score 5-14
* Investigator judgement on whether the participant is comfortable with technology
* Access to WiFi and a smart device for connecting on WebEx and downloading the Fitbit and Muse applications
* Have someone available to be present during all sessions

Exclusion Criteria:

* Unstable medical or psychiatric condition, including substance use based on an investigator opinion
* Visual or hearing impairments that would impair participation
* Patient Health Questionnaire score 15-27 and/or score of 1 or 2 in section E question 1 of the Cornell Scale for Depression in Dementia
* Any other reason, which will make the study participation intolerable for the participant in the opinion of the study investigator

Where it's running

  • Centre for Addictions and Mental Health (CAMH)
    Toronto, Ontario, Canada
    Recruiting

Study contacts

  • Principal investigator: HARMEHR SEKHON, PhD — CAMH and McGill/St. Mary's Research Centre
  • Study coordinator: Ashnie Sukhu, BSc
  • Email: ashnie.sukhu@camh.ca
  • Phone: (416) 535-8501

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.